臨床試験！

現在試験中の２抗体です！

臨床試験２段階Ｂ

有効効果１００人中９１人

現在大学病院にて、２００人試験中！

Anti-amylase peptides and

Anti-type 2 diabetes amino peptides

＜Testing＞

Mechanism

1. Inhibit the action of alpha-amylase, which is the enzyme that digests starches.

2. Inhibit the action of PTP1B，PTP1B can block the cell signal transduction and increased blood glucose levels.

3. Inhibit the Dipeptidyl Peptidase 4 (DPP-4) will increasing and prolonging the activity of the incretin.

Commercial Products:

Amylase inhibitors reduce the rate of digestion of starches in the small intestine. Isis Pharmaceuticals (Carlsbad, CA, USA) is also testing a PTP1b inhibitor, which is now in phase II trials. Merck Wins U.S. Approval for a New Diabetes Drug. DPP-4 Inhibitor for Type 2 Diabetes. And some company (Ex. Roche) has DPP-IV inhibitors in phase II and III trials.

Natural Ingredients: The new develop peptides are all-natural, non-hazardous and non-toxic products.

No Side Effect: Chemical drugs may have dangerous side effects. The peptides are easy to degrade without drugs or any side effects

Antibacterial peptide (Anti-multi-antibiotic staphylococcus)

＜testing＞

Antibiotic-resistant bacterium-- Staphylococcus aureus is the most notice bacterium of international. The American disease control center (CDC) believed that the minacity of the antibiotic-resistant staphylococcus is higher than the AIDS

l Dosage Forms：The anti- bacterial peptide use the oral administration way, and will not have intense allergic reaction, also without the drugs residues problems.

Natural Ingredients：Using antibiotic to prevent and cure the disease and infection is the common treatment in the past. However coming along with the environmental pollution and antibiotic-resistant problems cause the people's anxiety. Thus, using antibacterial peptide to replace antibiotic and chemical drugs is the trendy of the future.